- Report
- August 2021
- 114 Pages
Global
From €3200EUR$3,597USD£2,841GBP
- Report
- January 2020
- 40 Pages
United States
From €2473EUR$2,595USD£2,122GBP
- Report
- January 2020
- 40 Pages
Russia
From €2473EUR$2,595USD£2,122GBP
- Report
- January 2020
- 40 Pages
Ireland
From €2473EUR$2,595USD£2,122GBP
- Report
- January 2020
- 40 Pages
Germany
From €2473EUR$2,595USD£2,122GBP
- Report
- January 2020
- 40 Pages
China
From €2473EUR$2,595USD£2,122GBP
- Report
- January 2020
- 40 Pages
Brazil
From €2473EUR$2,595USD£2,122GBP
- Report
- January 2020
- 80 Pages
Africa
From €3617EUR$3,795USD£3,103GBP
- Report
- March 2024
- 132 Pages
Global
From €905EUR$950USD£777GBP
- Report
- November 2022
- 310 Pages
Global
From €3660EUR$3,840USD£3,140GBP
- Report
- October 2022
- 258 Pages
Global
From €3403EUR$3,570USD£2,919GBP
- Report
- May 2023
- 147 Pages
Global
From €5718EUR$5,999USD£4,905GBP
- Report
- December 2023
- 160 Pages
United States
From €5718EUR$5,999USD£4,905GBP
- Report
- December 2023
- 188 Pages
Asia Pacific
From €5718EUR$5,999USD£4,905GBP
- Report
- October 2023
- 158 Pages
Latin America
From €3335EUR$3,499USD£2,861GBP
- Report
- May 2022
- 108 Pages
Global
From €4051EUR$4,250USD£3,475GBP
- Report
- March 2022
- 124 Pages
Global
From €4289EUR$4,500USD£3,679GBP
- Report
- March 2020
- 117 Pages
Hungary
From €4098EUR$4,300USD£3,516GBP
- Book
- October 2012
- 1570 Pages
Toxoid vaccines are a type of vaccine that use a modified form of a toxin or toxin-producing microorganism to stimulate the body's immune system to produce antibodies against the toxin. The toxin is usually inactivated or weakened so that it does not cause disease, but still stimulates the body's immune system to produce antibodies. Toxoid vaccines are used to protect against a variety of diseases, including diphtheria, tetanus, and pertussis.
Toxoid vaccines are widely used in both developed and developing countries, and are an important part of routine immunization programs. They are also used in the prevention of certain occupational diseases, such as tetanus in healthcare workers.
The toxoid vaccine market is highly competitive, with a number of companies offering a range of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more